<code id='2BBF76C2F7'></code><style id='2BBF76C2F7'></style>
    • <acronym id='2BBF76C2F7'></acronym>
      <center id='2BBF76C2F7'><center id='2BBF76C2F7'><tfoot id='2BBF76C2F7'></tfoot></center><abbr id='2BBF76C2F7'><dir id='2BBF76C2F7'><tfoot id='2BBF76C2F7'></tfoot><noframes id='2BBF76C2F7'>

    • <optgroup id='2BBF76C2F7'><strike id='2BBF76C2F7'><sup id='2BBF76C2F7'></sup></strike><code id='2BBF76C2F7'></code></optgroup>
        1. <b id='2BBF76C2F7'><label id='2BBF76C2F7'><select id='2BBF76C2F7'><dt id='2BBF76C2F7'><span id='2BBF76C2F7'></span></dt></select></label></b><u id='2BBF76C2F7'></u>
          <i id='2BBF76C2F7'><strike id='2BBF76C2F7'><tt id='2BBF76C2F7'><pre id='2BBF76C2F7'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:7
          Pregnancy and clinical trials
          Adobe

          The FDA has taken a big step in encouraging drug companies to include pregnant women in clinical trials, issuing a draft guidance outlining how to do so safely and ethically.

          Nearly 4 million women in the U.S. give birth each year, but few drugs have been approved as safe and effective to use during pregnancy. The new guidance aims to help drug companies address those information gaps “through judicious inclusion of pregnant women in clinical trials and careful attention to potential fetal risk.”

          advertisement

          Experts say it’s a sign of progress on an issue that’s long plagued pregnant women and their physicians.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          CDC picks Alphabet's Verily for wasterwater surveillance contract
          CDC picks Alphabet's Verily for wasterwater surveillance contract

          AdobeAlphabet’slifesciencescompanyVerilyhasscoreditsfirstCentersforDiseaseControlandPreventioncontra

          read more
          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more

          FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

          MarkJ.Terrill/APAfollow-upstudyofafirst-of-its-kindcancertreatmentmayreflectsystemicbiases,theFoodan